GlycoFlux™ Human SIGLEC8 Overexpression A549 Cell Line

GlycoFlux™ human SIGLEC8 overexpression A549 cell line is a stable epithelial model engineered to express SIGLEC8, a CD33-related lectin located at 19q13.3-q13.4 and containing conserved ITIM and SLAM-like cytoplasmic motifs. Primarily expressed in hematopoietic cells, SIGLEC8 delivers inhibitory signaling through interactions with SLAM-associated protein. This model allows exploration of epithelial lectin function, glycan signaling, and immune regulation.

Overexpression Cell Lines

Human

Epithelial-like, adherent

1:3~1:6

A549

Non-small cell lung cancer

Lung

Non-small cell lung cancer

>90%

The sterility test indicated an absence of microbial growth.

STR identification

Negative

Negative for HIV, HBV and HCV.

We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.

qPCR, Sanger Sequencing

F-12K & FBS & Penicillin/Streptomycin

Mechanistic studies; Exploration of glycosylation and signaling pathways in cancer, metabolic, and immune-related diseases; Drug target validation and other functional assays.

1 M cells/vial*2

Frozen

Dry ice

Made to order

Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.

This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

SIGLEC8

Sialic Acid Binding Ig Like Lectin 8

SAF2, SIGLEC-8, SIGLEC8L, Sialic Acid Binding Ig Like Lectin

19q13.33-q13.41

Sialic acid-binding immunoglobulin (Ig)-like lectins, or SIGLECs (e.g., CD33 (MIM 159590)), are a family of type 1 transmembrane proteins each having a unique expression pattern, mostly in hemopoietic cells. SIGLEC8 is a member of the CD33-like subgroup of SIGLECs, which are localized to 19q13.3-q13.4 and have 2 conserved cytoplasmic tyrosine-based motifs: an immunoreceptor tyrosine-based inhibitory motif, or ITIM (see MIM 604964), and a motif homologous to one identified in signaling lymphocyte activation molecule (SLAM; MIM 603492) that mediates an association with SLAM-associated protein (SAP; MIM 300490).